PPD Development, LP Clinical Trials
Sponsors / PPD Development, LP
ClinicalTrials.gov lists 27 trials for which PPD Development, LP is named as lead sponsor. The portfolio currently includes 2 recruiting studies, 1 active non-recruiting studies, and 20 completed studies. 3 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Cumulative planned enrollment across all listed trials is 5,072 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
27
Total Trials
2
Recruiting
1
Other Active
20
Completed
3
Terminated / Withdrawn
5,072
Total Enrollment
Termination reasons: Recruitment67% · Safety33%
Recent Terminations
- Age-related Macular Degeneration"The study terminated for safety reasons"
- Bipolar Depressive Disorder"Study sponsor ended trial due to low recruitment"
- Diabetes"slow recruitment"
Active Trials (1 total)
- NCT07562087
- NCT05721937
- Acute Myeloid Leukemia PHASE3NCT04229979